drugset / Trial / NCT03836859
Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to assess the safety and tolerability of a single short-term and a multiple dose scheme of rhNGF when administered as eye drops in healthy subjects of Japanese ethnicity. The secondary objective of this study is to assess the pharmacokinetics of single and multiple doses of rhNGF when administered as eye drops in healthy subjects of Japanese ethnicity.
Timeline
- Start
- 2018-03-30
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhNGF | Protein / enzyme biologic | 20 ug/ml | Other |
Indications
No indication recorded.